EFFECTS OF TESTOSTERONE SUPPLEMENTATION ON MARKERS OF THE METABOLIC SYNDROME AND INFLAMMATION IN HYPOGONADAL MEN WITH THE METABOLIC SYNDROME: THE DOUBLE-BLINDED PLACEBO-CONTROLLED MOSCOW STUDY Article Kalinchenko S.Y., Tishova Y.A., Mskhalaya G.J., Gooren L.J.G., Giltay E.J., Saad F. Clinical Endocrinology. Vol. 73. 2010. P. 602-612
NO RECURRENCE OF PROSTATE CANCER AFTER 3 YEARS OF TESTOSTERONE TREATMENT AFTER RADICAL PROSTATECTOMY OF PROSTATE CANCER A CASE REPORT Article Mskhalaya G., Kalinchenko S., Tishova Y., Saad F. Journal of Men's Health. Vol. 7. 2010. P. 326-326
THE MOSCOW STUDY: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL OF PARENTERAL TESTOSTERONE UNDECANOATE ON THE METABOLIC SYNDROME AND INFLAMMATION MARKERS Article Kalinchenko S., Tishova Y., Mskhalaya G., Giltay E., Gooren L., Saad F. Journal of Sexual Medicine. Blackwell Publishing Ltd. Vol. 7. 2010. P. 103-103
EFFECTS OF TESTOSTERONE TREATMENT ON SYMPTOMS OF THE LOWER URINARY TRACT IN AGING MEN WITH HYPOGONADISM Article Mskhalaya G.J., Kalinchenko S., Vishnevskiy E.I., Koval A.N., Saad F. Journal of Men's Health. Vol. 6. 2009. P. 256-256